Feb. 23 at 4:50 PM
$CADL Imagine being able to buy shares in a company that has
$350 million COH, very little debt & a
$15-20 BILLION drug that has passed the FDA design approved Phase 3 trials with solid results & safety testing.
But, wait…there’s more! The company’s drug is also in advanced stages of development for several additional indications with remarkable success at every phase, which each address TAMs in the
$10’s of BILLIONS.
But, wait…there’s even more! Multiple Major Biotech Investment Funds are accumulating large positions in the Company’s stock.
But, wait…there’s still more! The company is right now preparing its NDA filing with the FDA for commercial authorization for its
$15-
$20 BILLION TAM drug by the 4th quarter of this year, which is just 6 months away!
But, wait…the best part is that right now you can buy shares of this company (CADL), which has fewer than 75 million shares outstanding following its latest cash raise, while the market cap is still at only
$267 million!
